Mometasone nasal spray: what to report after nasal surgery or injury?

Show the full name of your spray to the doctor or pharmacist before use, and report recent nasal surgery or injury. The cited guidance concerns MOMETASONE SANDOZ and NASONEX 50 micrograms/dose, suspensions for nasal spraying. The nasal route and exact presentation matter when checking the leaflet.

For these two presentations, the leaflets say not to use the spray after recent surgery or nasal injury until the wounds in the nose have healed. Clarify this restriction for your circumstances; choosing a number of days yourself does not establish that it has ended.

The product information explains the precaution: corticosteroids can inhibit wound healing. The spray acts on nasal inflammation, but that action does not remove the restriction linked to a wound. Ask the professional to check the planned use against your recent nasal history.

An untreated nasal infection, such as the herpes mentioned in the leaflets, is another restriction. These documents explain that the spray can worsen this infection and say to wait until it has healed before use. Report a known or suspected infection rather than deciding yourself that it has cleared.

Contact the doctor about persistent irritation of the nose or throat, or when treatment has been used for several months. The cited documents provide for this follow-up. The benzalkonium chloride present can cause irritation or swelling, especially with prolonged use; it does not explain every symptom with certainty.

The MOMETASONE SANDOZ leaflet says to stop this product and consult a doctor immediately for swelling of the face, tongue or pharynx, difficulty swallowing, hives, or wheezing or difficult breathing. These signs of a possible serious allergic reaction take priority over a prevention discussion.